We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
+5.64%
1 Year Est. Return
+16.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$97.7B
AUM Growth
+$13.4B
Cap. Flow
+$8.11B
Cap. Flow %
8.3%
Top 10 Hldgs %
14.79%
Holding
11,408
New
1,114
Increased
4,572
Reduced
4,158
Closed
1,006

Sector Composition

Rank Sector Weight
1 Energy 9.1%
2 Healthcare 6.42%
3 Technology 5.93%
4 Financials 5.8%
5 Industrials 5.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARRY
5251
DELISTED
Array Biopharma Inc
ARRY
$185K ﹤0.01%
29,805
+3,341
+13% +$19.8K
TEU
5252
DELISTED
BOX SHIPS INCORPORATED SHS (MARSHALL ISLANDS)
TEU
$185K ﹤0.01%
45,304
+20,130
+80% +$81.4K
HLSS
5253
PUT
DELISTED
HOME LN SERVICING SOLUTIONS LTD(CAYMAN ISLANDS)
HLSS
$185K ﹤0.01%
8,400
+200
+2% +$4.74K
MLU
5254
DELISTED
METLIFE, INC. COM EQUITY UNIT
MLU
$185K ﹤0.01%
6,473
-2,000
-24% -$69.6K
ET icon
5255
PUT
Energy Transfer Partners
ET
$70.1B
$184K ﹤0.01%
11,200
+1,200
+12% +$19.1K
FXF icon
5256
CALL
Invesco CurrencyShares Swiss Franc Trust
FXF
$414M
$184K ﹤0.01%
1,700
+1,200
+240% +$126K
PERI icon
5257
Perion Network
PERI
$375M
$184K ﹤0.01%
4,669
+4,637
+14,491% +$167K
PPG icon
5258
PUT
PPG Industries
PPG
$24.6B
$184K ﹤0.01%
2,200
-14,800
-87% -$1.18M
SGEN
5259
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
$184K ﹤0.01%
4,200
-3,300
-44% -$137K
ALR
5260
DELISTED
Alere Inc
ALR
$184K ﹤0.01%
6,018
+2,380
+65% +$72.5K
LF
5261
CALL
DELISTED
LEAPFROG ENTERPRISES INC.
LF
$184K ﹤0.01%
19,500
-6,500
-25% -$67.2K
CBST
5262
CALL
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$184K ﹤0.01%
2,900
-100
-3% -$6.04K
VPHM
5263
DELISTED
VIROPHARMA INC
VPHM
$184K ﹤0.01%
4,690
+2,855
+156% +$93.3K
BRT
5264
BRT Apartments
BRT
$281M
$183K ﹤0.01%
25,450
+1,667
+7% +$12K
EUO icon
5265
CALL
ProShares UltraShort Euro
EUO
$34.7M
$183K ﹤0.01%
10,300
-6,200
-38% -$115K
FLEX icon
5266
PUT
Flex
FLEX
$41.7B
$183K ﹤0.01%
26,673
-398
-1% -$2.62K
NOG icon
5267
PUT
Northern Oil and Gas
NOG
$2.3B
$183K ﹤0.01%
1,270
+190
+18% +$25.3K
BKCC
5268
CALL
DELISTED
BlackRock Capital Investment Corporation
BKCC
$183K ﹤0.01%
19,300
+10,300
+114% +$102K
CEA
5269
DELISTED
China Eastern Airlines
CEA
$183K ﹤0.01%
11,148
+8,267
+287% +$132K
HMIN
5270
PUT
DELISTED
HOMEINNS HOTEL GROUP SPONSORED ADR
HMIN
$183K ﹤0.01%
+5,500
New +$169K
RDA
5271
CALL
DELISTED
RDA MICROELECTRONICS INC SPONSORED ADR
RDA
$183K ﹤0.01%
+12,000
New +$143K
DSCI
5272
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$183K ﹤0.01%
14,716
+1,672
+13% +$23.1K
PLCM
5273
DELISTED
POLYCOM INC
PLCM
$183K ﹤0.01%
16,771
-35,770
-68% -$373K
ASPS icon
5274
Altisource Portfolio Solutions
ASPS
$63.6M
$182K ﹤0.01%
163
+57
+54% +$55.4K
GBX icon
5275
CALL
The Greenbrier Companies
GBX
$1.52B
$181K ﹤0.01%
7,300
+5,900
+421% +$137K

Similar funds

UBS's Q3 2013 Portfolio in Review

As of Q3 2013, UBS held 11,408 positions worth $97.7B, up 16% from $84.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS deployed $8.11B of net new capital in Q3 2013, opening 1,114 new positions and adding to 4,572 existing holdings. Its largest new stake was COLE REAL ESTATE INVESTMENTS, INC COM: 11,625,569 shares worth $143M.

By sector, the portfolio is most concentrated in Energy at 9.1% of assets, down from 9.5% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Nuance Communications, Inc., an estimated $308M trimmed.

  • UBS's largest Q3 2013 buy was COLE REAL ESTATE INVESTMENTS, INC COM: 11,625,569 shares worth $143M.
  • UBS added most to Mastercard in Q3 2013, an estimated $185M increase.
  • UBS's biggest Q3 2013 reduction was Nuance Communications, Inc., cutting an estimated $308M.
  • UBS fully exited THE NEWS CORPORATION LTD CL-B in Q3 2013, selling an estimated $30.8M.
  • UBS's ten largest holdings make up 15% of its $97.7B portfolio in Q3 2013.
  • UBS opened 1,114 new positions and closed 1,006 in Q3 2013.
  • UBS's portfolio value rose 16% quarter-over-quarter to $97.7B.

Based on UBS's 13F filing for Q3 2013, filed 13 Nov 2013.